Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
30.06.23
/
50%
€12.81
Target price
30.06.24
€15.60
Performance (%)
-90.29%
End price
01.07.24
€1.24
Summary
This prediction ended on 01.07.24 with a price of €1.24. The BUY prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc. performed very badly with a performance of -90.29%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pacific Biosciences of California Inc. | 12.007% | 12.007% | -3.266% | -88.619% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $17.00 price target on the stock.
Ratings data for PACB provided by MarketBeat
In the thread Trading Pacific Biosciences of California Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.26
10.04.24
10.04.24
€6.50
10.04.25
10.04.25
-62.31%
11.04.25
11.04.25
